Vaccine teams raring to go as SA jabbing campaign resumes
New protocols to include screening and monitoring of people at risk of rare blood clots
The vaccination of SA healthcare workers against Covid-19 will resume on Wednesday and the teams responsible have enough doses and are primed for action, said the scientists driving the delivery.
Prof Glenda Gray, co-principal investigator of the Sisonke implementation study, which is providing Covid-19 Johnson & Johnson (J&J) vaccines, said: “Our teams are raring to go and anxious to get back into the field and complete the study.”
The vaccinations were paused by the SA Health Products Regulatory Authority (Sahpra) on April 13, the same day the US Food and Drug Administration paused its J&J rollout because of extremely rare and severe blood clots (https://www.timeslive.co.za/sunday-times/news/2021-04-18-covid-19-vaccine-blood-clot-risk-rarer-than-a-double-lightning-strike/) detected in six out of 6.8 million Americans vaccinated...